Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTQG4NR)

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Discontinued Drug(s)

Clinical Trial Drug(s)

Download the Complete Related Drug List

5 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
LKA651	DMCFGP3	Diabetic macular edema	9B71.02	Phase 2	[1]
MK-2578	DM1M57I	Anemia	3A00-3A9Z	Phase 2	[2]
Erythropoietin-transfected autologous cell therapy	DMNZ6VA	Anemia	3A00-3A9Z	Phase 1/2	[3]
GC-1113	DMK96CE	Anemia	3A00-3A9Z	Phase 1	[4]
Long-acting erythropoietin conjugate	DM9OA35	Anemia	3A00-3A9Z	Phase 1	[5]
------------------------------------------------------------------------------------

2 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
FC EPO	DMEX12T	Anemia	3A00-3A9Z	Discontinued in Phase 1	[6]
GLY-515n	DM0IKB4	Cerebrovascular ischaemia	8B1Z	Terminated	[7]
------------------------------------------------------------------------------------

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Clinical pipeline report, company report or official report of Novartis.
2	Merck ditches biogeneric. Nat Biotechnol. 2010 Jul;28(7):636.
3	Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Mol Ther. 2009 Feb;17(2):369-72.
4	A long-acting erythropoietin fused with noncytolytic human Fc for the treatment of anemia. Arch Pharm Res. 2012 May;35(5):757-9.
5	Company report (Pharmexcil)
6	Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing. Drug Test Anal. 2012 Nov;4(11):818-29.
7	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027536)